Home LiteratureArticle Details
PMID: 1245938 Published · ppublish English Journal Article

Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine.

The Journal of pediatrics ·Vol. 88 ·No. 1 ·1976-01-00 ·Pages 26-30

Marine WM, Stuart-Harris C

Abstract

Infants, two years of age and under, received zonally purified whole-virus A/Aichi/2/68 (H3N2) influenza vaccine. Febrile responses, including one febrile convulsion, were observed in nine of 13 (69%). There was a fourfold rise in serum-neutralizing antibody in nine of 11 (82%) of those lacking initial antibody titers. Purity of the vaccine was documented by electron microscopy, absence of egg protein, and very low levels of endotoxin (0.048mug/dose). It is concluded that the toxicity of vaccine is related to the virus itself and that, despite the good antibody response, influenza vaccine should be administered only to children two years and under at high-risk of complications from influenza, if at all.

MeSH Terms
Adolescent Adult Aged Antibodies, Viral/analysis Antibody Formation Child Child, Preschool Endotoxins/analysis Fever/etiology Hemagglutination Inhibition Tests Humans Infant Influenza A virus/immunology Influenza Vaccines/administration & dosage,adverse effects,analysis Middle Aged Neutralization Tests Orthomyxoviridae/immunology
Chemicals
Antibodies, Viral Endotoxins Influenza Vaccines
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Marine W M
Stuart-Harris C
Article Info
Journal
The Journal of pediatrics
Abbr.
J Pediatr
ISSN
0022-3476
Published
1976-01-00
Pages
26-30
Language
English
Region
United States
NLM ID
0375410
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com